BWM
ABBV icon

Brophy Wealth Management’s AbbVie ABBV Stock Holding History

Brophy Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$207K Buy
+1,047
New +$195K 0.07% 204

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Brophy Wealth Management's ABBV Position: Q3 2024 in Review

Brophy Wealth Management opened a new position in AbbVie (ABBV) in Q3 2024: 1,047 shares worth $207K. The stake represents 0.07% of the portfolio and ranks #204 among its holdings.

3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Brophy Wealth Management held 1,047 shares of AbbVie worth $207K as of Q3 2024.
  • AbbVie was a new Brophy Wealth Management position in Q3 2024.
  • AbbVie made up 0.07% of Brophy Wealth Management's portfolio in Q3 2024, its #204 holding.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Brophy Wealth Management's 13F filing for Q3 2024, filed 15 Nov 2024.